Showing 5091-5100 of 5771 results for "".
- Eversight Awards 2019 Eye & Vision Research Grantshttps://modernod.com/news/eversight-awards-2019-eye-vision-research-grants/2476757/Eversight announced it has awarded grants through the Eversight Center for Vision and Eye Banking Research to investigators at Kellogg Eye Center at the University of Michigan Medical School, University of Illinois College of Medicine, Wayne State University School of Medicine, Harvard Medical Sc
- Bausch + Lomb Introduces 23-Gauge Bi-Blade Dual Port Vitrectomy Cutter for the Stellaris Elite Vision Enhancement Systemhttps://modernod.com/news/bausch-lomb-introduces-23-gauge-bi-blade-dual-port-vitrectomy-cutter-for-the-stellaris-elite-vision-enhancement-system/2476752/Bausch + Lomb announced the introduction of the 23-gauge Bi-Blade dual port vitrectomy cutter for the Stellaris Elite vision enhancement system. The new probe joins the available 25- and 27-gauge Bi-Blade cutters as options in the Bi-Blade portfolio. All Bi-Blade cutters double effective cut rate
- Notal Vision Diagnostic Clinic Reports Completion of 6 Million ForeseeHome AMD Home-Monitoring Testshttps://modernod.com/news/notal-vision-diagnostic-clinic-reports-completion-of-6-million-foreseehome-amd-home-monitoring-tests/2476750/Notal Vision announced the completion of 6 million patient tests performed with ForeseeHome, the first FDA-cleared home-monitoring device for patients with intermediate dry age-related macular degeneration (AMD) at risk for developing wet AMD, according to a company news release. ForeseeHo
- Altaire Pharmaceuticals Expands Voluntary Recall Of Multiple OTC Ophthalmic Productshttps://modernod.com/news/altaire-pharmaceuticals-expands-voluntary-recall-of-multiple-otc-ophthalmic-products/2476747/Altaire Pharmaceuticals announced that it is voluntarily recalling the over-the-counter (OTC) drug products and lots, within expiry, sold by Accutome, Focus Laboratories, Grandall Distributing Co., and Prestige Brands. As a precautionary measure, Altaire is voluntarily initiating the recall due t
- Nidek Launches LPM Low Power Mode for YLC-500 Vixihttps://modernod.com/news/nidek-launches-lpm-low-power-mode-for-ylc-500-vixi/2476744/Nidek has announced the launch of LPM optional software, a low power mode for the YLC-500 Vixi laser photocoagulator. LPM delivers a therapeutic effect to the retina by decreasing the laser power during photocoagulati
- FDA Accepts Allergan’s NDA for Bimatoprost SR in Patients With Glaucomahttps://modernod.com/news/fda-accepts-allergans-nda-for-bimatoprost-sustained-release-in-patients-with-open-angle-glaucoma-or-ocular-hypertension/2476739/Allergan announced that the FDA has accepted the company’s new drug application (NDA) for Bimatoprost Sustained-Release (SR) biodegradable implant for the reduction of IOP in patients with primary open-angle glaucoma or ocular hypertension. The FDA is expected to take action on the NDA by t
- Trefoil Therapeutics Raises $28 Million Series A to Advance Engineered FGF-1 for the Treatment of Corneal Diseaseshttps://modernod.com/news/trefoil-therapeutics-raises-28-million-series-a-to-advance-engineered-fgf-1-for-the-treatment-of-corneal-diseases/2476735/Trefoil Therapeutics announced it raised $28 million in an oversubscribed Series A financing. The company is developing novel engineered fibroblast growth factor-1 proteins (eFGF-1) as a regenerative pharmacologic therapy to treat serious corneal endothelial diseases and epithelial disorders.
- EKF Quo-Test Supports Improved Medical Management of Diabetic Retinopathy Patientshttps://modernod.com/news/ekf-quo-test-supports-improved-medical-management-of-diabetic-retinopathy-patients/2476736/EKF Diagnostics announced that its Quo-Test HbA1c analyzer is supporting improved medical management of patients with sight-threatening diabetic retinopathy (DR). The effectiveness of this point-of-care HbA1c testing application for rapid assessment of glycaemic control in eye clinic patients has
- Clerio Vision Acquires Manufacturer of Extreme H2O Contact Lenseshttps://modernod.com/news/clerio-vision-acquires-manufacturer-of-extreme-h2o-contact-lenses/2476732/Clerio Vision announced that it has acquired Hydrogel Vision Corporation (HVC), a manufacturer and distributor of contact lenses. Terms of the deal were not disclosed. HVC, founded in 2002, is best known for its Extreme H2O product line and its multiple differentiated offerings that
- Foundation Fighting Blindness Appoints Judy Taylor Vice President, Developmenthttps://modernod.com/news/foundation-fighting-blindness-appoints-judy-taylor-vice-president-development/2476733/The Foundation Fighting Blindness has announced that it has appointed Judy Taylor as vice president, development. In her new role, Ms. Taylor will be responsible and accountable for the strategic direction, planning and oversight of major gifts and planned giving function for the foundation.